QIAGEN CEO Thierry Bernard Hails Remarkable Quarter, Sees Bright Future on the Horizon

Q3 2023: Net sales of $476 million (-5% at actual rates, -6% at constant exchange rates, CER); diluted EPS of $0.34 and adjusted diluted EPS of $0.50 // Ne...

October 31, 2023 | Tuesday | Company results
Bio-Rad CEO, Norman Schwartz, Discusses Q3 Results and Adjusts 2023 Outlook Amid Biopharma Challenges

  Third-quarter 2023 total net sales were $632.1 million, a decrease of 7.1 percent compared to $680.8 million reported for the third quarter of 20...

October 30, 2023 | Monday | Company results
Fuelling Growth through Quality: A Candid Conversation with Lars Petersen, President and CEO of FUJIFILM Diosynth Biotechnologies, Unveiling the Key Role of Maja Pedersen

In the bustling halls of CPHI Barcelona, BioPharma BoardRoom had the privilege to sit down with Lars Petersen, the President and CEO of FUJIFILM Diosynth B...

October 27, 2023 | Friday | Interaction
Data and AI in Life Sciences: Shaping the Future - An Exclusive Interview with Mr. Shakthi Nagappan, CEO of Telangana Life Sciences

In a rapidly evolving world where data and artificial intelligence have become paramount, BioAsia 2024 presents a theme that transcends traditional boundar...

October 27, 2023 | Friday | Interaction
Marc Casper's Leadership Propels Thermo Fisher to Strong Q3 Performance Amid Market Challenges

Third Quarter 2023 Highlights Third quarter revenue was $10.57 billion, 1% lower versus the same quarter last year. Core organic revenue growth was 1%. ...

October 26, 2023 | Thursday | Company results
Merck CEO Belén Garijo Expresses Confidence in Resilient Growth Model for 2024

Transitional year 2023 managed well so far thanks to resilient business model Medium-term growth targets confirmed Merck expects continued growth also ...

October 25, 2023 | Wednesday | Company results
Novartis Reports Stellar Quarter with Double-Digit Sales Growth, CEO Vas Narasimhan Confident in Strong Mid-Term Outlook

Transformation into a “pure-play” innovative medicines business is complete, with the spin-off of Sandoz; commentary below is on continuing o...

October 24, 2023 | Tuesday | Company results
Roche CEO Thomas Schinecker Reflects on Impressive 2023 Results, Aims for a Bright Future Beyond COVID-19

Group sales grow by 1%1 at constant exchange rates (CER) in the first nine months, showing a strong increase of 7% in the third quarter Excluding COVID-...

October 20, 2023 | Friday | Company results
Agilent CEO Mike McMullen Emphasizes Corporate Role in Green Economy Transition and Sustainable Growth

Agilent Technologies Inc. announced the company’s near and long-term targets for reaching net-zero greenhouse gas emissions have been approved by the...

October 20, 2023 | Friday | News
Sartorius CEO Joachim Kreuzburg Foresees Gradual Recovery in 2023, Eyes Strong Growth in 2024 and Beyond

Sales revenue in constant currencies down 16.4 percent, excluding Covid-19-related business down slightly above 10 percent; underlying EBITDA marg...

October 20, 2023 | Friday | Company results
Malaysia Healthcare Travel Council Announces New Chief Executive Officer

Dr. Ali will be spearheading all aspects of MHTC’s operations, ensuring its commitment to facilitating and promoting the nation’s healthcare tr...

October 17, 2023 | Tuesday | News
Meeta Gulyani joins the Novo Holdings Advisory Group

Kasim Kutay, CEO of Novo Holdings, said: “With her extensive market knowledge and executive experience in the pharmaceutical and life science industr...

October 10, 2023 | Tuesday | News
QIAGEN's CEO, Thierry Bernard, Reaffirms Strong Commitment to Advancing Science and Improving Healthcare Access for a Better Planet and People

Progress on Environment, Social and Governance (ESG) goals reflected in QIAGEN securing a „Prime“ rating and among the industry leaders with IS...

September 28, 2023 | Thursday | Expert Opinion
MoleculeAI's Quest: Revolutionizing Drug Discovery with Artificial Intelligence

In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering t...

September 11, 2023 | Monday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close